首页> Oman journal of ophthalmology> Serum vascular endothelial growth factor in patients with nonmelanoma primary ocular malignancies: A possible potential biomarker of tumor progression and poor prognosis.

Serum vascular endothelial growth factor in patients with nonmelanoma primary ocular malignancies: A possible potential biomarker of tumor progression and poor prognosis.

导出 OA

翻译打印收藏纠错

第一作者： Rajendra Prakash,Maurya

第一单位： Regional Institute of Ophthalmology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

作者： Rajendra Prakash,Maurya ^[1] ; Anjali,Singh ^[2] ; Virendra Pratap,Singh ^[1] ; Sunit K,Singh ^[3] ; Raksha,Rao ^[4] ; Priyanka ^[1] ; Sneha,Gupta ^[1] ; Shalini,Ranjan ^[1] ; Manas,Ribhu ^[1] ; Abdullah S,Al-Mujaini ^[5]

作者单位： Regional Institute of Ophthalmology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India. ^[1] Department of Ophthalmology, Maharaja Suhel Dev Autonomous State Medical College, Bahraich, Uttar Pradesh, India. ^[2] Department of Molecular Biology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India. ^[3] Orbit, Ophthalmic Plastic Surgery and Ophthalmic Oncology, Narayana Nethralaya, Narayana Health City, Bengaluru, Karnataka, India. ^[4] Department of Ophthalmology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman. ^[5]

关键词 Angiogenesis metastasis ocular malignancy tumor markers vascular endothelial growth factor

DOI 10.4103/ojo.ojo_20_25

PMID 41230057

发布时间 2025-11-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交